Relmada Therapeutics Inc
F:4E2
Relmada Therapeutics Inc
F:4E2
Price:
6.5
EUR
6.56%
Market Closed
Market Cap:
€195.6m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Relmada Therapeutics Inc
F:4E2
|
US |
|
A
|
Accuray Inc
F:XEJ
|
US |
|
B
|
Brunswick Corp
F:BWI
|
US |
|
M
|
Mettler-Toledo International Inc
XMUN:MTO
|
US |
|
Bollore SE
F:BOP
|
FR |
|
B
|
Blackstone Inc
F:BBN1
|
US |
|
V
|
Verizon Communications Inc
SGO:VZ
|
US |
|
C
|
Clean Harbors Inc
SWB:CH6
|
US |
|
J
|
JPMorgan Chase & Co
SGO:JPM
|
US |
|
M
|
Mitsubishi Corp
OTC:MSBHF
|
JP |
|
Sekisui House Ltd
F:SPH1
|
JP |
|
H
|
Honda Motor Co Ltd
XHAM:HDM
|
JP |
|
Discovery Ltd
F:D3H0
|
ZA |
|
C
|
Continental AG
OTC:CTTAY
|
DE |
|
C
|
Compagnie Generale des Etablissements Michelin SCA
F:MCH
|
FR |
|
S
|
Stockland Corporation Ltd
F:LN1
|
AU |
DCF Valuation
is not available for Relmada Therapeutics Inc
is not available for Relmada Therapeutics Inc
Relmada Therapeutics Inc's DCF value cannot be reliably calculated.
Switch to
See Also
Other Relmada Therapeutics Inc listings:
Discover More
